Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1

S. Shin, L. Wolgamott, J. Tcherkezian, S. Vallabhapurapu, Y. Yu, P. P. Roux, S. O. Yoon

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Protein synthesis has a key role in the control of cell proliferation, and its deregulation is associated with pathological conditions, notably cancer. Rapamycin, an inhibitor of mammalian target of rapamycin complex 1 (mTORC1), was known to inhibit protein synthesis. However, it does not substantially inhibit protein synthesis and cell proliferation in many cancer types. We were interested in finding a novel target in rapamycin-resistant cancer. The rate-limiting factor for translation is eukaryotic translation initiation factor 4E (eIF4E), which is negatively regulated by eIF4E-binding protein 1 (4E-BP1). Here, we provide evidence that glycogen synthase kinase (GSK)-3β promotes cell proliferation through positive regulation of protein synthesis. We found that GSK-3β phosphorylates and inactivates 4E-BP1, thereby increasing eIF4E-dependent protein synthesis. Considering the clinical relevance of pathways regulating protein synthesis, our study provides a promising new strategy and target for cancer therapy.

Original languageEnglish (US)
Pages (from-to)1690-1699
Number of pages10
JournalOncogene
Volume33
Issue number13
DOIs
StatePublished - Mar 27 2014

Fingerprint

Glycogen Synthase Kinase 3
Peptide Initiation Factors
Carrier Proteins
Eukaryotic Initiation Factor-4E
Cell Proliferation
Eukaryotic Initiation Factors
Proteins
Sirolimus
Neoplasms
Critical Pathways

Keywords

  • 4E-BP1
  • GSK-3
  • Translation

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1. / Shin, S.; Wolgamott, L.; Tcherkezian, J.; Vallabhapurapu, S.; Yu, Y.; Roux, P. P.; Yoon, S. O.

In: Oncogene, Vol. 33, No. 13, 27.03.2014, p. 1690-1699.

Research output: Contribution to journalArticle

Shin, S. ; Wolgamott, L. ; Tcherkezian, J. ; Vallabhapurapu, S. ; Yu, Y. ; Roux, P. P. ; Yoon, S. O. / Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1. In: Oncogene. 2014 ; Vol. 33, No. 13. pp. 1690-1699.
@article{72d765293cec4c14a1d98a697b1f7ee8,
title = "Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1",
abstract = "Protein synthesis has a key role in the control of cell proliferation, and its deregulation is associated with pathological conditions, notably cancer. Rapamycin, an inhibitor of mammalian target of rapamycin complex 1 (mTORC1), was known to inhibit protein synthesis. However, it does not substantially inhibit protein synthesis and cell proliferation in many cancer types. We were interested in finding a novel target in rapamycin-resistant cancer. The rate-limiting factor for translation is eukaryotic translation initiation factor 4E (eIF4E), which is negatively regulated by eIF4E-binding protein 1 (4E-BP1). Here, we provide evidence that glycogen synthase kinase (GSK)-3β promotes cell proliferation through positive regulation of protein synthesis. We found that GSK-3β phosphorylates and inactivates 4E-BP1, thereby increasing eIF4E-dependent protein synthesis. Considering the clinical relevance of pathways regulating protein synthesis, our study provides a promising new strategy and target for cancer therapy.",
keywords = "4E-BP1, GSK-3, Translation",
author = "S. Shin and L. Wolgamott and J. Tcherkezian and S. Vallabhapurapu and Y. Yu and Roux, {P. P.} and Yoon, {S. O.}",
year = "2014",
month = "3",
day = "27",
doi = "10.1038/onc.2013.113",
language = "English (US)",
volume = "33",
pages = "1690--1699",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "13",

}

TY - JOUR

T1 - Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1

AU - Shin, S.

AU - Wolgamott, L.

AU - Tcherkezian, J.

AU - Vallabhapurapu, S.

AU - Yu, Y.

AU - Roux, P. P.

AU - Yoon, S. O.

PY - 2014/3/27

Y1 - 2014/3/27

N2 - Protein synthesis has a key role in the control of cell proliferation, and its deregulation is associated with pathological conditions, notably cancer. Rapamycin, an inhibitor of mammalian target of rapamycin complex 1 (mTORC1), was known to inhibit protein synthesis. However, it does not substantially inhibit protein synthesis and cell proliferation in many cancer types. We were interested in finding a novel target in rapamycin-resistant cancer. The rate-limiting factor for translation is eukaryotic translation initiation factor 4E (eIF4E), which is negatively regulated by eIF4E-binding protein 1 (4E-BP1). Here, we provide evidence that glycogen synthase kinase (GSK)-3β promotes cell proliferation through positive regulation of protein synthesis. We found that GSK-3β phosphorylates and inactivates 4E-BP1, thereby increasing eIF4E-dependent protein synthesis. Considering the clinical relevance of pathways regulating protein synthesis, our study provides a promising new strategy and target for cancer therapy.

AB - Protein synthesis has a key role in the control of cell proliferation, and its deregulation is associated with pathological conditions, notably cancer. Rapamycin, an inhibitor of mammalian target of rapamycin complex 1 (mTORC1), was known to inhibit protein synthesis. However, it does not substantially inhibit protein synthesis and cell proliferation in many cancer types. We were interested in finding a novel target in rapamycin-resistant cancer. The rate-limiting factor for translation is eukaryotic translation initiation factor 4E (eIF4E), which is negatively regulated by eIF4E-binding protein 1 (4E-BP1). Here, we provide evidence that glycogen synthase kinase (GSK)-3β promotes cell proliferation through positive regulation of protein synthesis. We found that GSK-3β phosphorylates and inactivates 4E-BP1, thereby increasing eIF4E-dependent protein synthesis. Considering the clinical relevance of pathways regulating protein synthesis, our study provides a promising new strategy and target for cancer therapy.

KW - 4E-BP1

KW - GSK-3

KW - Translation

UR - http://www.scopus.com/inward/record.url?scp=84898014860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898014860&partnerID=8YFLogxK

U2 - 10.1038/onc.2013.113

DO - 10.1038/onc.2013.113

M3 - Article

C2 - 23584478

AN - SCOPUS:84898014860

VL - 33

SP - 1690

EP - 1699

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 13

ER -